NURO CORP
Guelph, Ontario (ON), Canada
Healthcare
Products & Services
NO VOICE NO TOUCH JUST BRAIN
NURO CORP
NUOS is the World’s first ZERO-SURGERY neurotechnology able to adapt instantly to a wide variety of conditions such as Stroke, Trauma and Neurodegenerative Diseases.
Our products allow Communication and Computing by Brain and can be deployed with most human beings indoors or outdoors in seconds, regardless of your state of health.
Watch here some of our current work as well as our past achievements built from the ground up...
Our products allow Communication and Computing by Brain and can be deployed with most human beings indoors or outdoors in seconds, regardless of your state of health.
Watch here some of our current work as well as our past achievements built from the ground up...
NUOS MOBILE 2
NURO CORP
NUOS MOBILE 2 redefines neurologically-based communication for incapacitated individuals. Our users can now communicate using key neurological signals and do so instantly and without any surgery. In addition, NURO is making NUOS MOBILE 2 a perfect entry package for early stage patients to start using the NUOS platform at an affordable price.
NUOS MOBILE 2 runs on Android Phones and is an advanced technological all-in-one platform composed of custom hardware, software and algorithms which allows a training-less experience based on the particular pathophysiological capabilities of each user.
NUOS MOBILE 2 comes with lightweight neurological sensors set on the NURO Glasses (2nd Generation available now in 4 Styles for Men, Women, Teens and Children), its custom software application and free unlimited support and updates.
NUOS MOBILE 2 runs on Android Phones and is an advanced technological all-in-one platform composed of custom hardware, software and algorithms which allows a training-less experience based on the particular pathophysiological capabilities of each user.
NUOS MOBILE 2 comes with lightweight neurological sensors set on the NURO Glasses (2nd Generation available now in 4 Styles for Men, Women, Teens and Children), its custom software application and free unlimited support and updates.
People
News
OUR REASON FOR BEING
NURO was born from trauma and neurodegeneration and our founders have directly experienced what you are facing today. That you are dealing with a stroke, a trauma, a neurodegenerative disease, a serious infection, we have developed tools to help you and that is the reason why we exist.
Our firm offers groundbreaking, reliable, ethical, cruelty-free and surgery-free solutions with superior ease of use, rapid deployment capability and at reasonable prices for all human beings across the World.
Our firm offers groundbreaking, reliable, ethical, cruelty-free and surgery-free solutions with superior ease of use, rapid deployment capability and at reasonable prices for all human beings across the World.
10 Jan 2023
NURO unveils the PAD, a novel and patented neurotechnology for the detection and the monitoring of Alzheimer's disease
NURO, the global leader in non-invasive neurotechnology, announces new patented architecture to diagnose and track Alzheimer's disease.
WATERLOO, ONTARIO, CANADA, December 12, 2022 /EINPresswire.com/ -- NURO, known for the NUOS product line which allows patients to communicate and compute by Brain instantly and without any surgery, is now unveiling its second major surgery-free neurotechnology: The PAD.
The PAD is a groundbreaking tool to provide early detection and continuous monitoring of Alzheimer's disease. Composed of multiple layers of technology seamlessly scanning and evaluating various areas of the brain subject to this devastating condition, this new wireless device is primarily aimed at assisting physicians in Primary Care with this overwhelming problem.
"Multi-million dollar installations of MRI and CT/PET scanners are available in the wealthiest countries and largest metropolitan areas yet Alzheimer's is still diagnosed and tracked very much empirically in many parts of the World and it is time for a much more affordable and portable solution to be implemented to not only diagnose these patients as early as possible but also track their progression easily, consistently and at a fraction of the price." says Francois Gand, the Founder and CEO of NURO, the Creator of the PAD and whose father passed away from the disease.
The PAD provides a brand new, non-invasive, rapid methodology which is based on multimodal sensors, multimodal signal processing, key algorithms and AI Deep Learning in a wireless helmet form factor. This particular approach gives unprecedented neurological insights to local clinicians and their patients who may be subject to developing or are developing Alzheimer's disease by allowing each scan to be compared live by Artificial Intelligence across de-identified records of other PAD scans.
This novel approach has been further reinforced recently by several research breakthroughs in the understanding of this complex disease which revealed very specific pathophysiological, structural and cerebrovascular changes in the brain, all events that are technically and scientifically trackable by the patented PAD technology.
Via its innovative combination of various sensors and processing, the PAD is a first-in-class technology to precisely evaluate and monitor such neurological disorders over time and at a very large scale, assisting directly clinicians and researchers to tackle the disease.
"One of the major shortcomings in our search for more precise diagnoses and treatment for Alzheimer's disease has been our inability to detect and monitor the course of the disease. It is a privilege to be part of the group that has now made a profound advance in this vital area of medicine. We are quite excited about our novel and patented technology for Alzheimer's disease and its possibilities to reduce long term burden." states Dr. David J. Kupfer, MD, on behalf of the Board of Directors of NURO.
Dr. David J. Kupfer, MD, one of the key pillars of US Psychiatry and Neurology, is the Chair of the DSM-5 Global Task Force, which includes more than 160 mental health and medical professionals who are leaders in their respective fields. He is also the author of over 1,000 scientific articles, books and book chapters and has been the recipient of numerous awards and honours, including being elected to the Institute of Medicine of the National Academy of Sciences for his contributions to Medical Sciences, Health Care, and Public Health.
Dr. Jay Lombard, MD, also an internationally-acclaimed Neurologist, Author and Keynote Speaker, who has published significant scientific literature on the pathophysiology of Alzheimer's disease, agrees: "Beyond amazing. I mean remarkably beyond. The PAD is a master achievement for the good of the world."
WATERLOO, ONTARIO, CANADA, December 12, 2022 /EINPresswire.com/ -- NURO, known for the NUOS product line which allows patients to communicate and compute by Brain instantly and without any surgery, is now unveiling its second major surgery-free neurotechnology: The PAD.
The PAD is a groundbreaking tool to provide early detection and continuous monitoring of Alzheimer's disease. Composed of multiple layers of technology seamlessly scanning and evaluating various areas of the brain subject to this devastating condition, this new wireless device is primarily aimed at assisting physicians in Primary Care with this overwhelming problem.
"Multi-million dollar installations of MRI and CT/PET scanners are available in the wealthiest countries and largest metropolitan areas yet Alzheimer's is still diagnosed and tracked very much empirically in many parts of the World and it is time for a much more affordable and portable solution to be implemented to not only diagnose these patients as early as possible but also track their progression easily, consistently and at a fraction of the price." says Francois Gand, the Founder and CEO of NURO, the Creator of the PAD and whose father passed away from the disease.
The PAD provides a brand new, non-invasive, rapid methodology which is based on multimodal sensors, multimodal signal processing, key algorithms and AI Deep Learning in a wireless helmet form factor. This particular approach gives unprecedented neurological insights to local clinicians and their patients who may be subject to developing or are developing Alzheimer's disease by allowing each scan to be compared live by Artificial Intelligence across de-identified records of other PAD scans.
This novel approach has been further reinforced recently by several research breakthroughs in the understanding of this complex disease which revealed very specific pathophysiological, structural and cerebrovascular changes in the brain, all events that are technically and scientifically trackable by the patented PAD technology.
Via its innovative combination of various sensors and processing, the PAD is a first-in-class technology to precisely evaluate and monitor such neurological disorders over time and at a very large scale, assisting directly clinicians and researchers to tackle the disease.
"One of the major shortcomings in our search for more precise diagnoses and treatment for Alzheimer's disease has been our inability to detect and monitor the course of the disease. It is a privilege to be part of the group that has now made a profound advance in this vital area of medicine. We are quite excited about our novel and patented technology for Alzheimer's disease and its possibilities to reduce long term burden." states Dr. David J. Kupfer, MD, on behalf of the Board of Directors of NURO.
Dr. David J. Kupfer, MD, one of the key pillars of US Psychiatry and Neurology, is the Chair of the DSM-5 Global Task Force, which includes more than 160 mental health and medical professionals who are leaders in their respective fields. He is also the author of over 1,000 scientific articles, books and book chapters and has been the recipient of numerous awards and honours, including being elected to the Institute of Medicine of the National Academy of Sciences for his contributions to Medical Sciences, Health Care, and Public Health.
Dr. Jay Lombard, MD, also an internationally-acclaimed Neurologist, Author and Keynote Speaker, who has published significant scientific literature on the pathophysiology of Alzheimer's disease, agrees: "Beyond amazing. I mean remarkably beyond. The PAD is a master achievement for the good of the world."
10 Jan 2023
About
NURO is committed to pushing the boundaries of technology for the well-being and betterment of human kind. We focus on complex problems and deliver powerful, innovative and safe solutions. We thrive in reaching further, deeper and in unprecedented ways.
Learn how NURO came to be and join us in this quest. That you are a client, a partner, an investor, let us build together solutions aiming to transform and enhance Life.
Learn how NURO came to be and join us in this quest. That you are a client, a partner, an investor, let us build together solutions aiming to transform and enhance Life.
